The Evolution Development.
Partnering with NAVCO is an opportunity.
Drug Development.
Preclinical efficacy data yields better clinical results and ensures the regulator’s expediency. Our design team will work closely with you to determine what is relevant, from morphological and biochemical changes to full-spectrum efficacy, toxicology, and monitoring of your trials.
We use only suitable in vitro application for each tested drug to optimize the outcome of the study, such as cell culture study will determine the affect of the novel drug, pre, during and post clinical testing. Our testing is focusing on using a combination of two approaches genomic testing and biomarkers. In the simplest terms, our translational studies bring certitude to “go or no-go” decisions and help de-risk drug development programs.
Computation performance across all species of interest
New drug design and application process
In-vitro drug dial in process to achieve maximum performance
Molecular isolation and diagnostics
RNA and DNA end point identification
In house top notch clinical design team
NAVCO partners with clinical trial companies giving you access to multiple end points
